These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cyclosporine for induction of remission in Crohn's disease. McDonald JW; Feagan BG; Jewell D; Brynskov J; Stange EF; Macdonald JK Cochrane Database Syst Rev; 2005 Apr; (2):CD000297. PubMed ID: 15846602 [TBL] [Abstract][Full Text] [Related]
25. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. Prefontaine E; Macdonald JK; Sutherland LR Cochrane Database Syst Rev; 2010 Jun; (6):CD000545. PubMed ID: 20556747 [TBL] [Abstract][Full Text] [Related]
26. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study. Ardizzone S; Bollani S; Manzionna G; Imbesi V; Colombo E; Bianchi Porro G Dig Liver Dis; 2003 Sep; 35(9):619-27. PubMed ID: 14563183 [TBL] [Abstract][Full Text] [Related]
27. [Successful primary infliximab treatment of orofacial Crohn's disease without gastrointestinal manifestation]. Jung BY; Lee SH; Chung SK; Lee CK; Lee TH; Chung IK; Kim SJ; Cho HD Korean J Gastroenterol; 2012 Jun; 59(6):437-40. PubMed ID: 22735878 [TBL] [Abstract][Full Text] [Related]
28. Drug therapy of inflammatory bowel disease. Sack DM; Peppercorn MA Pharmacotherapy; 1983; 3(3):158-76. PubMed ID: 6136027 [TBL] [Abstract][Full Text] [Related]
29. Natalizumab for induction of remission in Crohn's disease. Macdonald JK; McDonald JW Cochrane Database Syst Rev; 2006 Jul; (3):CD006097. PubMed ID: 16856112 [TBL] [Abstract][Full Text] [Related]
30. [Anti-TNF therapy in treatment of luminal Crohn's disease]. Marko B; Prka L Acta Med Croatica; 2013 Apr; 67(2):179-89. PubMed ID: 24471301 [TBL] [Abstract][Full Text] [Related]
31. A comparison of budesonide with prednisolone for active Crohn's disease. Rutgeerts P; Löfberg R; Malchow H; Lamers C; Olaison G; Jewell D; Danielsson A; Goebell H; Thomsen OO; Lorenz-Meyer H N Engl J Med; 1994 Sep; 331(13):842-5. PubMed ID: 8078530 [TBL] [Abstract][Full Text] [Related]
32. Steroid-induced psychosis in an adolescent: treatment and prophylaxis with risperidone. Hergüner S; Bilge I; Yavuz Yilmaz A; Tüzün DU Turk J Pediatr; 2006; 48(3):244-7. PubMed ID: 17172069 [TBL] [Abstract][Full Text] [Related]
33. [Azathioprine in chronic inflammatory bowel diseases. Evidence base]. Herrlinger K; Stange EF Med Klin (Munich); 2000 Apr; 95(4):201-6. PubMed ID: 10808301 [TBL] [Abstract][Full Text] [Related]
34. Natalizumab for induction of remission in Crohn's disease. MacDonald JK; McDonald JW Cochrane Database Syst Rev; 2007 Jan; (1):CD006097. PubMed ID: 17253580 [TBL] [Abstract][Full Text] [Related]
35. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Prefontaine E; Sutherland LR; Macdonald JK; Cepoiu M Cochrane Database Syst Rev; 2009 Jan; (1):CD000067. PubMed ID: 19160175 [TBL] [Abstract][Full Text] [Related]
36. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease. Panés J; López-Sanromán A; Bermejo F; García-Sánchez V; Esteve M; Torres Y; Domènech E; Piqueras M; Gomez-García M; Gutiérrez A; Taxonera C; Sans M; Gastroenterology; 2013 Oct; 145(4):766-74.e1. PubMed ID: 23770132 [TBL] [Abstract][Full Text] [Related]
37. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease. Gelbmann CM; Rogler G; Gross V; Gierend M; Bregenzer N; Andus T; Schölmerich J Am J Gastroenterol; 2002 Jun; 97(6):1438-45. PubMed ID: 12094862 [TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease. Behm BW; Bickston SJ Cochrane Database Syst Rev; 2008 Jan; (1):CD006893. PubMed ID: 18254120 [TBL] [Abstract][Full Text] [Related]
39. Experience with the use of low-dose methotrexate for inflammatory bowel disease. Soon SY; Ansari A; Yaneza M; Raoof S; Hirst J; Sanderson JD Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):921-6. PubMed ID: 15316419 [TBL] [Abstract][Full Text] [Related]
40. Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease. Kamm MA; Hanauer SB; Panaccione R; Colombel JF; Sandborn WJ; Pollack PF; Zhou Q; Robinson AM Aliment Pharmacol Ther; 2011 Aug; 34(3):306-17. PubMed ID: 21645018 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]